Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.57 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.57 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.38 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | DAO | P14920 | 2/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.36 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.35 |
| ▸ | DDO | Q99489 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL581645 | 0.84 | GABRA1 (0.48) | GABRA1GABRB2KCNH2SCN5ATAAR1 | |
| SCHEMBL6656641 | 0.82 | GABRA1 (0.46) | GABRA1GABRB2HTR1ATAAR1 | |
| SCHEMBL7309326 | 0.80 | GABRA1 (0.44) | GABRA1GABRB2DAO | |
| SCHEMBL3561165 | 0.80 | GABRA1 (0.44) | GABRA1GABRB2MGLLPDK2MAPT | |
| SCHEMBL3563149 | 0.77 | PDCD1 (0.50) | GABRA1GABRB2 | |
| SCHEMBL22686109 | 0.76 | GABRA1 (0.46) | GABRA1GABRB2MGLLPDK2 | |
| SCHEMBL201763 | 0.76 | BID (0.44) | GABRA1GABRB2 | |
| SCHEMBL25425763 | 0.76 | GABRA1 (0.58) | GABRA1GABRB2MGLLMAPTNPSR1 | |
| SCHEMBL36294 | 0.76 | GABRA1 (0.58) | GABRA1GABRB2MGLLMAPTNPSR1 | |
| SCHEMBL29390847 | 0.76 | GABRA1 (0.58) | GABRA1GABRB2MGLLMAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4365180-A1 | RARE EARTH COMPLEX | Tosoh Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| CN-117616032-A | Rare earth complex | 东曹株式会社 | 2024-02-27 | — | — | CN | disclosed |
| EP-2435497-B1 | POLYCYCLIC DITHIOPHENES | CLAP CO LTD (KR) | 2023-07-05 | — | — | EP | disclosed |
| WO-2023282236-A1 | RARE EARTH COMPLEX | 東ソー株式会社 | 2023-01-12 | — | — | WO | disclosed |
| US-20210340346-A1 | METAL FILM-COATED MOLDED RESIN ARTICLES AND PRODUCTION METHOD THEREFOR | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2021-11-04 | — | — | US | disclosed |
| EP-3851553-A1 | METAL-COATED MOLDED RESIN ARTICLES AND PRODUCTION METHOD THEREFOR | Mitsubishi Engineering-Plastics Corporation (JP) | 2021-07-21 | — | — | EP | disclosed |
| US-10988494-B2 | Europium complex | TOSOH CORPORATION (JP) | 2021-04-27 | — | — | US | disclosed |
| CN-112654728-A | Resin molded article with metal film and method for producing same | 三菱工程塑料株式会社 | 2021-04-13 | — | — | CN | disclosed |
| US-20200354389-A1 | EUROPIUM COMPLEX | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2020-11-12 | — | — | US | disclosed |
| EP-2315502-B1 | Electroluminescent device | UDC IRELAND LTD (IE) | 2020-10-14 | — | — | EP | disclosed |
| US-5356966-A | Stabilizing organic material against oxidative, thermal or light iinduced degradation | CIBA-GEIGY CORPORATION (US) | 1994-10-18 | — | — | US | disclosed |
| EP-0619290-A2 | Salts of alkaline earth metals and transition metals as well as complexes of transition metals of ketocarboxylic acids and their use as corrosion inhibitors | CIBA-GEIGY AG (CH) | 1994-10-12 | — | — | EP | disclosed |
| US-5340701-A | Photoinitiators | CIBA-GEIGY CORPORATION (US) | 1994-08-23 | — | — | US | disclosed |
| EP-0590451-A1 | Process for acylation of aromatic compounds | BASF Aktiengesellschaft (DE) | 1994-04-06 | — | — | EP | disclosed |
| EP-0422535-B1 | Polymerisable perylene-3,4,9,10-tetracarboxylic diimides and polymeric products thereof | BASF AG (DE) | 1994-03-02 | — | — | EP | disclosed |
| EP-0565488-A1 | Fluorine free titanocenes and their application | CIBA-GEIGY AG (CH) | 1993-10-13 | — | — | EP | disclosed |
| EP-0432445-B1 | FLUORESCENT PRINTING INK | BASF Lacke + Farben AG (DE) | 1993-06-02 | — | — | EP | disclosed |
| US-5151516-A | Unsaturated monomers | BASF AKTIENGESELLSCHAFT (DE) | 1992-09-29 | — | — | US | disclosed |
| EP-0432445-A2 | Fluorescent printing ink | BASF Lacke + Farben AG (DE) | 1991-06-19 | — | — | EP | disclosed |
| EP-0422474-A2 | Fluorescent pigments | BASF Aktiengesellschaft (DE) | 1991-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10988494-B2 | Europium complex | SSB, XPA, UACA | GABRA1 1741/4885GABRB2 2075/4885MGLL 3864/4885 |
| US-20200354389-A1 | EUROPIUM COMPLEX | SSB, XPA, UACA | GABRA1 1741/4885GABRB2 2075/4885MGLL 3864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.